HIPSCORE
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98686425
- Registration number
- 8091273
- Mark type
- Stylized text
- Filed
- 07 Aug 2024
- Published for opposition
- 18 Nov 2025
- Registered
- 06 Jan 2026
- Attorney of record
- Gerard T. Gallagher
Goods and services
- Class 005 — Pharmaceuticals: Tissues for surgical use being surgical implants comprised of living tissues based on human induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use using human-induced pluripotent stem cells
- Class 042 — Scientific and technological services: Scientific and technological services;, namely, scientific research, analysis, testing, and evaluation in the field of human-induced pluripotent stem cells; Scientific and technological services, namely, testing in the field of human-induced pluripotent stem cells; authentication in the field of human-induced pluripotent stem cells; quality control for others in the field of human-induced pluripotent stem cells
Owner
- IUF Leibniz-Institut für umweltmedizinische Forschung GmbH, Düsseldorf, DE
- IUF Leibniz-Institut für umweltmedizinische Forschung GmbH, Düsseldorf, DE
- IUF Leibniz-Institut für umweltmedizinische Forschung GmbH, Düsseldorf, DE
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 24 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Nov 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2025 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 26 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 26 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 26 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 12 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED